A Bayesian phase I/II design for cancer clinical trials combining an immunotherapeutic agent with a chemotherapeutic agent

Beibei Guo, Suyu Liu, Elizabeth Garrett-Mayer

Publication date: 27 November 2024

Published in: Journal of the Royal Statistical Society. Series C. Applied Statistics (Search for Journal in Brave)

zbMATH Keywords

immunotherapy dose-finding drug combination Bayesian adaptive design risk-benefit tradeoff

Mathematics Subject Classification ID

Applications of statistics (62Pxx)

This page was built for publication: A Bayesian phase I/II design for cancer clinical trials combining an immunotherapeutic agent with a chemotherapeutic agent